bpc-157 typical dosage for healing dosing protocol human BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved what is the recommended dosage
Description
However, injections focus only on one nutrient

61 As a result, the stem cells in the scaffold released IL-1Ra in a sustained fashion over the course of 28 days in culture

Mayo Clinic Staff

It also provides ongoing support through a HIPAA-secure portal, allowing you to reach out with any questions or concerns about your treatment